ADENOCARCINOMA
Clinical trials for ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail for advanced kidney cancer shows early promise, but trial halted
Disease control TerminatedThis study tested a new drug (NKT2152) combined with two other medicines (palbociclib and sasanlimab) in people with advanced clear cell kidney cancer that had worsened after prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was …
Matched conditions: ADENOCARCINOMA
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Targeted lung cancer drug tested against chemo in phase 3 trial
Disease control TerminatedThis study tested a new targeted pill, pralsetinib, against standard chemotherapy for people with a specific type of advanced lung cancer (RET fusion-positive) who had not yet received treatment. The goal was to see if the targeted drug could delay cancer growth better than chemo…
Matched conditions: ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Gene test for lung cancer treatment falls short
Knowledge-focused TerminatedThis study aimed to see if genome sequencing could help doctors choose better treatments for people with multiple lung cancer tumors. It planned to enroll 100 adults with early-stage lung adenocarcinoma. However, the study was stopped early, so no clear conclusions were reached.
Matched conditions: ADENOCARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC